Skip to main content
Skip to main content
NAII logo

Natural Alternatives International, Inc. (NAII)

$2.23 $-0.05 (-2.19%) |Weak · 34
Bottom line: SELL — our Council read (34/100) and AI Score (34/100) broadly agree.
MCap: $13.99M| Vol: 3.5K|
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Natural Alternatives International, Inc. (NAII) trades at $2.23 with AI Score 34/100 (Grade D). Natural Alternatives International, Inc. formulates, manufactures, and markets nutritional supplements. Market cap: $13.99M, Sector: Consumer defensive.

Price live · AI analysis from May 10, 2026
Natural Alternatives International, Inc. formulates, manufactures, and markets nutritional supplements. They operate through private-label contract manufacturing and patent/trademark licensing.

Analyst Coverage for NAII: NAII does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates NAII against Consumer Defensive peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.

Council Score · Weighted Average of 3 Disciplines
SELL 34/100 · D

NAII: 1/1 perspectives are bearish.

How is this calculated? →
Council Score · 8 perspectives · See tabs for details →

Natural Alternatives International, Inc. (NAII) Consumer Business Overview

CEOMark A. LeDoux
Employees296
HeadquartersCarlsbad, CA, US
IPO Year1993

Natural Alternatives International, Inc. (NAII) operates within the consumer defensive sector, focusing on formulating, manufacturing, and marketing nutritional supplements. The company differentiates itself through private-label contract manufacturing and the licensing of its CarnoSyn and SR CarnoSyn brands, serving both direct-to-consumer and retail channels internationally.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: May 10, 2026

What Is the Investment Thesis for NAII?

Natural Alternatives International, Inc. presents a focused investment opportunity within the consumer defensive sector, specifically in the nutritional supplement market. The company's dual revenue streams—private-label contract manufacturing and patent licensing—provide diversification. However, a current profit margin of -9.1% warrants careful consideration. Growth catalysts include expanding its CarnoSyn brand and securing new private-label manufacturing contracts. Key value drivers are its established manufacturing capabilities and strategic partnerships. Investors should monitor the company's ability to improve profitability and manage competition within the nutritional supplement industry. The company's beta of 0.39 suggests lower volatility compared to the broader market.

Based on FMP financials and quantitative analysis

NAII Key Highlights

  • Market capitalization of $13.99M, indicating a small-cap company.
  • Gross margin of 8.6%, reflecting the profitability of its product sales after deducting direct costs.
  • Beta of 0.39, suggesting lower volatility compared to the overall market.
  • Operates in two segments: Private-Label Contract Manufacturing and Patent and Trademark Licensing, diversifying its revenue streams.
  • Serves customers through direct sales, e-commerce channels, and retail stores, providing broad market access.

Who Are NAII's Competitors?

NAII is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
USNA USANA Health Sciences, Inc. $21.24 -5.09% $392.15M 78
NUTR NUSATRIP Inc $41.80 +0.00% $628.33M 59
GPAGF Gruma, S.A.B. de C.V. $18.50 +0.00% $6.31B 66
PNGAF Pangea Wellness Inc. $0.39 +6.46% $5.86M 65
ZHYBF Zhong Yuan Bio-Technology Holdings Limited $2.02 +0.00% $35.75M 64
BOF BranchOut Food Inc. $4.45 +0.57% $68.08M 61
WESTW Westrock Coffee Company, LLC $1.92 +29.73% $168.42M 51
PTCXF PT Wilmar Cahaya Indonesia Tbk. $0.11 +0.00% $70.48M 51

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are NAII's Key Strengths?

  • Proprietary ingredients like CarnoSyn.
  • Established manufacturing capabilities.
  • Strategic partnering services.
  • International regulatory compliance expertise.

What Are NAII's Weaknesses?

  • Low profit margin (-9.1%).
  • Small market capitalization ($0.02B).
  • Limited brand recognition compared to larger competitors.
  • Dependence on a limited number of key customers.

What Could Drive NAII Stock Higher?

  • Potential new contracts for private-label manufacturing in the next 12-18 months.
  • Continued expansion of the CarnoSyn brand in the sports nutrition market.
  • Growth in the e-commerce channel for nutritional supplements.

What Are the Key Risks for NAII?

  • Financial-distress signal — its Altman Z-Score of 1.53 sits in the distress zone (elevated bankruptcy risk).
  • Negative return on equity (-21.5%) — the business is not currently generating profit on shareholder capital.
  • Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
  • Increased competition from larger contract manufacturers.
  • Regulatory changes impacting the nutritional supplement industry.
  • Fluctuations in raw material costs.
  • Dependence on key customer relationships.

What Are the Growth Opportunities for NAII?

  • Expansion of CarnoSyn Brand: NAII has the opportunity to further expand the market penetration of its CarnoSyn and SR CarnoSyn beta-alanine ingredients. The global beta-alanine market is projected to grow, driven by increasing demand from the sports nutrition and dietary supplement sectors. By investing in marketing and distribution, NAII can capitalize on this trend and increase its licensing revenue. Timeline: Ongoing.
  • Strategic Partnerships: Forming strategic partnerships with larger nutritional supplement companies and retailers can provide NAII with access to new markets and distribution channels. These partnerships can also lead to increased contract manufacturing orders and brand awareness. The strategic partnership market is constantly evolving, with companies seeking to expand their reach and product offerings. Timeline: Ongoing.
  • Product Innovation: Investing in research and development to create new and innovative nutritional supplement formulations can drive growth. By developing proprietary ingredients and products, NAII can differentiate itself from competitors and attract new customers. The nutritional supplement market is highly competitive, with companies constantly seeking to innovate and improve their product offerings. Timeline: Ongoing.
  • International Expansion: Expanding its operations into new international markets can provide NAII with significant growth opportunities. Emerging markets, in particular, offer strong growth potential due to increasing disposable incomes and growing health awareness. International expansion requires careful planning and execution, but the potential rewards are substantial. Timeline: Ongoing.
  • E-commerce Growth: Capitalizing on the growth of e-commerce by expanding its online presence and direct-to-consumer sales channels. The e-commerce market for nutritional supplements is growing rapidly, providing NAII with the opportunity to reach a wider audience and increase sales. Investing in digital marketing and online customer service is essential for success in this channel. Timeline: Ongoing.

What Opportunities Does NAII Have?

  • Expansion of CarnoSyn brand into new markets.
  • Strategic partnerships with larger companies.
  • Product innovation and development of new formulations.
  • Growth in e-commerce and direct-to-consumer sales.

What Threats Does NAII Face?

  • Intense competition in the nutritional supplement industry.
  • Changing consumer preferences and trends.
  • Regulatory changes and compliance requirements.
  • Economic downturns and reduced consumer spending.

What Are NAII's Competitive Advantages?

  • Proprietary Ingredients: Patented ingredients like CarnoSyn provide a competitive advantage.
  • Manufacturing Expertise: Established expertise in formulating and manufacturing nutritional supplements.
  • Strategic Partnerships: Long-term relationships with key customers and partners.
  • Regulatory Compliance: Expertise in navigating international regulatory and label law compliance.

What Does NAII Do?

Founded in 1980 and headquartered in Carlsbad, California, Natural Alternatives International, Inc. (NAII) has evolved into a key player in the nutritional supplement industry. The company operates through two primary segments: Private-Label Contract Manufacturing and Patent and Trademark Licensing. NAII provides comprehensive private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal supplements, and other health-related products. These services encompass customized product formulation, clinical studies, manufacturing, marketing support, international regulatory compliance, product registration, packaging design, and scientific research. NAII also licenses its patented beta-alanine ingredient under the CarnoSyn and SR CarnoSyn brands. The company manufactures products in various forms, including capsules, tablets, chewable wafers, and powders, catering to a diverse range of customer needs. NAII's strategic partnering services extend to packaging and delivery system design, regulatory review, and customer-specific nutritional product formulation. The company serves a broad clientele, including companies that market nutritional supplements through direct sales, e-commerce, and retail channels, operating in the United States, Europe, Asia, and internationally.

What Products and Services Does NAII Offer?

  • Formulates nutritional supplements.
  • Manufactures nutritional supplements in various forms (capsules, tablets, powders).
  • Markets nutritional supplements internationally.
  • Provides private-label contract manufacturing services.
  • Licenses patents and trademarks for ingredients like CarnoSyn.
  • Offers strategic partnering services including product formulation and regulatory compliance.

How Does NAII Make Money?

  • Generates revenue through private-label contract manufacturing of nutritional supplements.
  • Earns licensing fees from its patented CarnoSyn and SR CarnoSyn ingredients.
  • Provides strategic partnering services to nutritional supplement companies.
  • Sells its products to companies that market through direct sales, e-commerce, and retail channels.

What Industry Does NAII Operate In?

Natural Alternatives International, Inc. operates in the competitive packaged foods industry, specifically within the nutritional supplement segment. The global nutritional supplement market is characterized by increasing consumer awareness of health and wellness, driving demand for vitamins, minerals, and herbal supplements. Key trends include personalized nutrition, clean label products, and e-commerce growth. NAII competes with other contract manufacturers and ingredient suppliers, differentiating itself through its CarnoSyn brand and comprehensive service offerings. The company's success depends on its ability to innovate, maintain quality standards, and adapt to changing consumer preferences.

Who Are NAII's Key Customers?

  • Companies that market nutritional supplements through direct sales channels.
  • Companies that market nutritional supplements through direct-to-consumer e-commerce channels.
  • Companies that market nutritional supplements through retail stores.
  • Other health care product companies.
AI Confidence: 73% Updated: May 10, 2026

F-Score 3/9Financial Health

Natural Alternatives International, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 1.53 places it in the distress zone, a signal of elevated financial risk.

ROE -21%Key Financial Metrics

Return on equity for Natural Alternatives International, Inc. stands at -21.5%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -9.3%, showing how much profit it generates from its asset base. Its free cash flow yield is -58.9%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.64 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -97.7%, the inverse of the P/E and a quick read on earnings relative to price.

Natural Alternatives International, Inc. (NAII) Valuation Context

Valued at $13.99M, NAII is classified as a micro-cap stock. Relative to its peer group, NAII's quantitative score of 34/100 is below the peer average of 66/100.

Net buyingInsider Activity

Over the past six months, Natural Alternatives International, Inc. insiders filed 23 SEC Form 4 transactions — 3 sales and 20 purchases. On net that is roughly 68K shares acquired (about $9K) — insiders putting money in tends to read as conviction.

NAII Financials

Fundamental Snapshot

Revenue Growth (FY)
+14.1%
Net Income Growth (FY)
-88.1%
EPS Growth (FY)
-85.4%
Free Cash Flow Growth (FY)
+151.4%
Return on Equity (TTM)
-21.5%
Current Ratio
1.6

Based on FMP financials and quantitative analysis · FY 2024

Bull Case vs Bear Case

Bull Case

  • NAII insiders seem to be holding steady, suggesting they believe in the company's long-term prospects. This can signal confidence from those who know the business best.
  • The community seems to be buzzing about NAII's potential expansion into new markets, seeing it as a growth catalyst. This positive sentiment can attract more investors.
  • NAII's focus on health and wellness aligns with current consumer trends, giving them an edge in a growing market. This positions them well for sustained demand.
  • There's a general feeling that NAII is undervalued compared to its peers, creating an opportunity for potential upside. This perception could lead to increased buying pressure.

Bear Case

  • Some community members are concerned about increased competition in the dietary supplement space, which could squeeze NAII's margins. Intense competition often leads to price wars.
  • Recent market volatility has created an overall cautious sentiment, making investors hesitant to jump into smaller cap stocks like NAII. Uncertainty breeds fear.
  • There's chatter about potential regulatory hurdles that NAII might face, which could impact their ability to operate smoothly. Regulatory headwinds can be a significant drag.
  • A segment of the community believes NAII is too reliant on a few key products, making them vulnerable to changing consumer preferences. Lack of diversification is a common concern.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

NAII Latest News

NAII Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for NAII.

Price Targets

Wall Street price target analysis for NAII.

NAII MoonshotScore

34/100

What does this score mean?

The MoonshotScore rates NAII's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Leadership: Mark A. LeDoux

CEO

Mark A. LeDoux has served as the Chief Executive Officer of Natural Alternatives International, Inc. since its inception. His extensive background in the nutritional supplement industry spans several decades. He has been instrumental in guiding the company's strategic direction and fostering its growth. LeDoux's expertise encompasses product development, manufacturing, marketing, and international regulatory compliance. He is a recognized leader in the industry and has been actively involved in shaping industry standards and regulations.

Track Record: Under Mark A. LeDoux's leadership, Natural Alternatives International, Inc. has established itself as a reputable provider of private-label contract manufacturing services and a leading supplier of beta-alanine ingredients. He has overseen the expansion of the company's manufacturing facilities and the development of its strategic partnering services. LeDoux has also been instrumental in securing key customer relationships and driving the growth of the CarnoSyn brand.

Natural Alternatives International, Inc. Consumer Defensive Stock: Key Questions Answered

What does Natural Alternatives International, Inc. do?

Natural Alternatives International, Inc. (NAII) formulates, manufactures, and markets nutritional supplements in the United States, Europe, Asia, and internationally. The company operates through two segments: Private-Label Contract Manufacturing and Patent and Trademark Licensing. NAII provides private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal supplements, and other health-related products. It also licenses its patented beta-alanine ingredient under the CarnoSyn and SR CarnoSyn brands. The company serves customers through direct sales, e-commerce channels, and retail stores.

What do analysts say about NAII stock?

As of 2026-05-10, analyst coverage of Natural Alternatives International, Inc. (NAII) is limited due to its small market capitalization. Key valuation metrics include its market cap of $13.99M and a negative profit margin of -9.1%. Growth considerations revolve around the company's ability to expand its CarnoSyn brand, secure new private-label contracts, and improve profitability. Investors should monitor the company's financial performance and competitive positioning within the nutritional supplement industry. Analyst ratings and price targets are not widely available.

What are the main risks for NAII?

Natural Alternatives International, Inc. (NAII) faces several risks, including intense competition in the nutritional supplement industry, which could pressure pricing and market share. Regulatory changes impacting the industry could increase compliance costs and limit product offerings. Fluctuations in raw material costs could impact profitability. The company's dependence on key customer relationships poses a risk if those relationships are disrupted. Additionally, economic downturns could reduce consumer spending on nutritional supplements.

What are the key factors to evaluate for NAII?

Natural Alternatives International, Inc. (NAII) holds an AI score of 34/100 (low). Not financial advice.

How frequently does NAII data refresh on this page?

NAII prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.

What has driven NAII's recent stock price performance?

Natural Alternatives International, Inc. (NAII) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Proprietary ingredients like CarnoSyn. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider NAII overvalued or undervalued right now?

Valuing Natural Alternatives International, Inc. (NAII) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

What research should beginners do before buying NAII?

Before investing in Natural Alternatives International, Inc. (NAII), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Information is based on available company data and industry reports.
  • Financial data is as of the latest available reporting period.
  • Analyst opinions are based on limited coverage.
Data Sources

Popular Stocks